The abstract is read at the publisher; the summary is JClub's.
zDEVD-FMK inhibits CASP1-mediated processing of IL-1β and IL-18 despite CASP1 showing minimal activity toward the DEVD fluorogenic substrate, revealing protease- and substrate-dependent off-target specificity.
- Why it matters: Fluorogenic tetrapeptide assays are commonly used to validate caspase inhibitor specificity, but it is unclear whether they predict inhibition of endogenous protein substrates during real inflammatory signaling.
- What they did: The study tested zDEVD-FMK and Ac-YVAD-CMK against endogenous cytokine and apoptotic substrates, comparing endogenous cleavage to fluorogenic CASP3/7 and CASP1/7 reporter readouts during inflammasome activation and Salmonella infection.
- The result: IL-1β and IL-18 processing were inhibited more efficiently than gasdermin D cleavage, while fluorogenic reporter cleavage overestimated inhibition of endogenous apoptotic substrates; DEVD- and YVAD-based inhibitors did not distinguish apoptotic executioner from inflammatory caspase activity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.